SCHEMBL26510935

SCHEMBL26510935

CC(C)(COC(C)(C)CCn1cc(COC#N)nn1)NC(=O)COCC=O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26494489 0.91 — —
SCHEMBL24642806 0.81 HSP90AB1 (0.30) GLA
SCHEMBL26511031 0.75 — —
SCHEMBL26493363 0.69 — —
SCHEMBL26495656 0.68 CYP19A1 (0.35) —
SCHEMBL24642359 0.64 KDR (0.31) —
SCHEMBL23974348 0.62 OPRM1 (0.35) —
SCHEMBL22059717 0.60 NR1H4 (0.39) —
SCHEMBL22059738 0.60 NR1H4 (0.39) —
SCHEMBL20216912 0.60 DGAT1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4257154-A1 BIOACTIVE SUBSTANCE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF Medilink Therapeutics (Suzhou) Co., Ltd. (CN) 2023-10-11 — — EP disclosed
Send feedback